Diabetic Neuropathy: Clinical Trials

8 trials for Diabetic Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated. 8 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 7, Terminated 1
Phase 23Completed 2, Terminated 1

Follow Diabetic Neuropathy: new trials by email Literature Review of Diabetic Neuropathy trials Research Report on Diabetic Neuropathy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CGM-Guided Acarbose for Painful Diabetic Neuropathy
Acarbose 50 mg, Placebo - Diabetes, Diabetes Complications
Phase 1CompletedShifa International Hospital1702025-09-012026-03-03
Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
BOL-DP-o-04, Placebo - Diabetic Neuropathy
Phase 1 / Phase 2TerminatedBreath of Life International Pharma Ltd22019-04-152021-03-24
Less Neuropathy After Yoga- Managing Diabetic Neuropathy With Yoga
yoga - Diabetic Neuropathy
Phase 1CompletedColorado State University152014-09-012016-01-20
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
600㎍ of DA-3030 Injection, Placebo - Diabetic Neuropathy
Phase 1CompletedDong-A Pharmaceutical Co., Ltd.312010-06-012013-08-13
Neuropathic Pain Syndrome Patient Study (MK-0000-072)
Comparator: pregabalin, Comparator: Placebo (unspecified) - Neuralgia, Postherpetic, Diabetic Neuropathy
Phase 1CompletedMerck Sharp & Dohme LLC1042007-12-012015-05-07
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
AV411 - Diabetic Neuropathy
Phase 1 / Phase 2CompletedAvigen362006-09-012007-12-19
Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy
hVEGF-A - Diabetic Neuropathy
Phase 1CompletedSangamo Therapeutics122005-04-012011-06-08
VEGF Gene Transfer for Diabetic Neuropathy
VEGF - Diabetic Neuropathy
Phase 1 / Phase 2CompletedLosordo, Douglas, M.D.602002-12-012010-11-11

Narrower conditions

Diabetic Neuropathies (8)  ·  Diabetes Mellitus (3)  ·  Diabetes Complications (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Peripheral Arterial Disease (1)

Broader conditions

Endocrine System Diseases (8)  ·  Nervous System Diseases (8)  ·  Neuromuscular Diseases (8)  ·  Peripheral Nervous System Diseases (8)  ·  Diabetes Complications (7)  ·  Diabetes Mellitus (5)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)

Interventions

Acarbose (1)  ·  Vascular Endothelial Growth Factor A (1)  ·  Yoga (1)  ·  ibudilast (1)

Sponsors

Avigen (1)  ·  Breath of Life International Pharma Ltd (1)  ·  Colorado State University (1)  ·  Dong-A Pharmaceutical Co., Ltd. (1)  ·  Losordo, Douglas, M.D. (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Sangamo Therapeutics (1)  ·  Shifa International Hospital (1)

Countries

United States (2)  ·  Australia (1)  ·  Israel (1)  ·  Pakistan (1)  ·  South Korea (1)

Top investigators

Allan H Ropper, M.D. (1)  ·  Bong Yeon Cha, M.D., Ph.D. (1)  ·  Choon Hee Chung, M.D., Ph.D. (1)  ·  In Joo Kim, M.D., Ph.D. (1)  ·  Kyung Soo Ko, M.D, Ph.D. (1)  ·  Tae Sun Park, M.D., Ph.D. (1)  ·  Yoo Heon Ahn, M.D., Ph.D. (1)  ·  Young Soo Park, M.D.,Ph.D. (1)

Results publications

PMID 21185118